Jci_page_head_homepage_01 Jci_page_head_homepage_02
Pamela Poblete-Gutiérrez, Tonio Wiederholt, Arne König, Frank K. Jugert, Yvonne Marquardt, Albert Rübben, Hans F. Merk, Rudolf Happle, Jorge Frank
Published in Volume 114, Issue 10
J Clin Invest. 2004; 114(10):1467–1474 doi:10.1172/JCI21791
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 5

Microdissection analysis in a segmental skin area. (A) Liquid coverslip–embedded tissue section displaying intraepidermal blister formation, indicated by an arrow. (B) The same area after laser-assisted microdissection. (CE) Electropherograms showing restriction fragment length analysis of PCR-amplified DNA encompassing the splice donor site of exon 22 that was cleaved with BsaAI. Asterisks indicate the positions of the 75-bp and 100-bp peaks of the molecular size marker GeneScan-350. y-axis values measured in arbitrary fluorescence intensity units. (C) Control DNA only reveals the 72-bp dye-labeled wild-type fragment. (D) DNA obtained from the patient’s blood displays the 72-bp wild-type fragment and the 114-bp mutant (mut.) fragment. (E) DNA obtained from microdissected tissue only shows the mutant product of 114 bp, which is indicative of LOH.